AlphaValue/Baader Europe on Tuesday downgraded biopharmaceutical group Sartorius Stedim Biotech (DIM.PA) to add from buy and kept the price target at 217.00 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)